HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Xianglai Xu Selected Research
Xianglai Xu Research Topics
Disease
11
Renal Cell Carcinoma (Grawitz Tumor)
12/2024 - 09/2021
11
Neoplasms (Cancer)
04/2024 - 12/2012
8
Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 06/2013
3
Prostatic Neoplasms (Prostate Cancer)
11/2017 - 07/2013
3
Carcinogenesis
11/2013 - 08/2013
2
Neoplasm Metastasis (Metastasis)
11/2013 - 07/2013
1
Hyperplasia
11/2017
1
Genetic Predisposition to Disease (Genetic Predisposition)
12/2012
Drug/Important Bio-Agent (IBA)
12
Biomarkers (Surrogate Marker)
IBA
04/2024 - 11/2013
9
Tyrosine Kinase Inhibitors
IBA
12/2024 - 01/2023
8
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
12/2024 - 01/2023
8
MicroRNAs (MicroRNA)
IBA
11/2017 - 07/2013
2
Cyclin D1
IBA
11/2017 - 01/2015
2
Apigenin
IBA
02/2015 - 06/2013
1
Galectin 1 (LGALS1)
IBA
04/2024
1
Phosphotransferases (Kinase)
IBA
04/2024
1
Annexin A2 (Annexin II)
IBA
03/2024
1
Immune Checkpoint Inhibitors
IBA
01/2024
1
Oxidoreductases (Dehydrogenase)
IBA
01/2023
1
Proline (L-Proline)
FDA Link
01/2023
1
Heme Oxygenase-1
IBA
01/2023
1
delta-1-pyrroline-5-carboxylate
IBA
01/2023
1
Cyclin-Dependent Kinase 6
IBA
09/2014
1
Proteins (Proteins, Gene)
FDA Link
11/2013
1
Luciferases
IBA
11/2013
1
Messenger RNA (mRNA)
IBA
11/2013
1
Plasminogen Activators (Plasminogen Activator)
IBA
12/2012
1
Plasminogen
IBA
12/2012
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
12/2012
1
Plasminogen Activator Inhibitor 1
IBA
12/2012
Therapy/Procedure
10
Immunotherapy
12/2024 - 01/2023
8
Therapeutics
12/2024 - 08/2013
1
Nephrectomy
01/2023